Robert Thomas Fremeau Jr., Chief Scientific Officer at Vyant Bio, Inc. (VYNT), bought 1,000 shares at $2.19 ($2K) on 2021-10-28, disclosed to the SEC on 2021-11-17.
Open-market purchase of $2k VYNT by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.